Vulvovaginal Candidiases
Conditions
Keywords
Candidiases, Vaginal Infections
Brief summary
Epidemiological study about the clinical and microbiological progress in subjects under treatment for a severe vulvovaginal candidiases episody
Interventions
None listed
Sponsors
Dr. Santiago Palacios
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Sexually active women between 18 and 50 years of age at time of screening * With diagnosis and symptomatology of VVC
Exclusion criteria
* Pregnant women * Diabetes Mellitus * Women witihin three months after a delivery or misbirth * Women with vaginal or genital infection symptomatology other than candidiases that needs antibiotic treatment * Vaginal probiotics use within last three months * Undiagnosed abnormal genital hemorrhage
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Estimate cure rate in women with severe vuvovaginal candidiases infection | At 3 months | Women must require antimicotic treatment plus vaginal probiotic following the habitual therapeutic standards |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Estimate recurrences | At 6 months | It will be consider recurrences an asymptomatic period for 7-10 days and a negative culture |
| Evaluate the link between symptomatology and negative culture | At 3 months | — |
| Evaluate the effectiveness of probiotic treatment by physician | At 3 months | A gynecological exploration will be performed |
| Evaluate the effectiveness of probiotic treatment by patient. A satisfaction questionnaire will be performed | At 3 months | The subject will be asked how long the symptoms lasted and the gravity of them |
Countries
Spain
Outcome results
None listed